Pharmacological activities of potent medicinal plant Adhatoda zeylanica medic: A review

Authors

  • Sutare MS Department of Botany, Shri YPSC Solankur Dist Kolhapur Affiliated to Shivaji University Kolhapur (MS)
  • Kareppa BM 2HOD, Department of Botany and Biotechnology, DSM College Parabhani, Affiliated to Swami Ramanand Terth Marathwada University Nanded (MS), India.

Abstract

Plants are the major source of medicines from ancient times. Nowadays, there is a growing demand of medicines particularly belonging to plant drugs. Medicinal plants have various complex chemical substances as secondary plant metabolites. The plant Adhatoda zeylanica Medic. syn. A. vasica Nees (Adulsa) is also one of the natural wealth among plants. Adulsa is mostly used against, tumours, leprosy, blood disorders, ear diseases, asthma, fever, thirst, vomiting, loss of memory, leucoderma, bronchitis jaundice, etc. Present paper focus on medicinal property of Adulsa based on collected data through literature review. The review focuses on the phytochemistry and pharmacological actions of the plant.

 Keywords: Adhatoda, Adulsa, phytochemistry, pharmacology, vasicine, vasicinone

Downloads

Download data is not yet available.

Additional Files

Published

2020-07-30

How to Cite

Sutare MS, & Kareppa BM. (2020). Pharmacological activities of potent medicinal plant Adhatoda zeylanica medic: A review. International Journal of Life Sciences, 55–58. Retrieved from https://ijlsci.in/ls/index.php/home/article/view/78

Issue

Special issue, A14 | June 2020

Section

Special issue

License

Copyright (c) 2020 Sutare MS , Kareppa BM

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license unless indicated otherwise in a credit line to the material. If the material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/ licenses/by/4.0/